abstract |
The disclosure relates to thecompound2-(cyclohexylmethyl)-N-{2-[(2S)-1- methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamideor a pharmaceutically acceptable salt thereof, intended forthe treatment of Alzheimer's disease and other types of dementia. |